Can Stereotactic Ablative Radiotherapy (SABR) Improve Patient Selection for Lung Cancer Surgery and Reduce Perioperative Mortality?

被引：0
|
作者：
Serrano, Nicholas [1 ]
Adams, Bret [2 ]
Szentpetery, Szabolcs [3 ]
Rogers, C. Leland [4 ]
Chang, Michael [4 ]
Moghanaki, Drew [4 ]
机构：
[1] Virginia Commonwealth Univ, Radiat Oncol, Richmond, VA USA
[2] Univ Miami, Radiat Oncol, Miami, FL USA
[3] Hunter Holmes Mcguire Vet Affairs Med Ctr, Thorac Surg, Richmond, VA USA
[4] Hunter Holmes Mcguire Vet Affairs Med Ctr, Radiat Oncol, Richmond, VA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
SABR; NSCLC; stereotactic;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MINI18.13
引用
收藏
页码：S329 / S329
页数：1
相关论文
共 50 条
  • [1] Can Stereotactic Ablative Radiation Therapy (SABR) Improve Patient Selection for Lung Cancer Surgery and Reduce Perioperative Mortality?
    Serrano, N.
    Adams, B.
    Szentpetery, S.
    Rogers, L.
    Chang, M. G.
    Moghanaki, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E409 - E409
  • [2] Can patient selection for stereotactic ablative radiotherapy (SABR) in patients with early stage lung cancer patients be improved by a central multidisciplinary team?
    Moore, K.
    Harrow, S.
    Hicks, J.
    Lumsden, G.
    Featherstone, C.
    Mohammed, N.
    Clark, B.
    McKay, S.
    McLoone, P. M.
    LUNG CANCER, 2018, 115 : S59 - S60
  • [3] Stereotactic Ablative Radiotherapy (SABR) for Non-Small Cell Lung Cancer
    Iyengar, Puneeth
    Westover, Kenneth
    Timmerman, Robert D.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (06) : 845 - 854
  • [4] A case for development of stereotactic ablative body radiotherapy (SABR) for lung cancer at Aberdeen
    Stilwell, C.
    Steven, E.
    Sharma, R. N.
    Bissett, D.
    Shrimali, R. K.
    LUNG CANCER, 2013, 79 : S58 - S59
  • [5] Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer
    Desai, Neil B.
    Laine, Aaron M.
    Timmerman, Robert D.
    BRITISH JOURNAL OF RADIOLOGY, 2017, 90 (1070):
  • [6] Factors Affecting Use of Stereotactic Ablative Radiotherapy (SABR) in Patients with Inoperable Lung Cancer
    Syed, Mohshin
    Jayasekera, Geeshath
    Rushd, Farwah
    LUNG CANCER, 2025, 200
  • [7] Prognostic role of texture analysis in lung cancer treated with stereotactic ablative radiotherapy (SABR)
    Nardone, V.
    Tini, P.
    Mazzoni, L. N.
    La Penna, A.
    Biondi, M.
    Sebaste, L.
    Carfagno, T.
    Vanzi, E.
    De Otto, G.
    Battaglia, G.
    Pastina, P.
    Carbone, S. F.
    Buonamici, F. Banci
    Pirtoli, L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [8] Stereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumours
    Goldsmith, Christy
    Gaya, Andrew
    CANCER IMAGING, 2012, 12 (02): : 351 - 360
  • [9] A national program for the implementation of lung Stereotactic Ablative Body Radiotherapy (SABR)
    Diez, P.
    Haridass, A.
    Lilley, J.
    Patel, R.
    Miles, E.
    Tree, A.
    Clark, C.
    Dean, C.
    Fell, K.
    McDonald, F.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S868 - S870
  • [10] Spatial Assessment of Dose Distributions for Patients with Lung Cancer Treated with Stereotactic Ablative Radiotherapy (SABR)
    Liu, D.
    Chen, D.
    Chetvertkov, M.
    Altman, M.
    Li, H.
    Wen, N.
    Glide-Hurst, C.
    Ajlouni, M.
    Levin, K.
    Movsas, B.
    Chetty, I.
    MEDICAL PHYSICS, 2012, 39 (06) : 3817 - 3817
12345